{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Andrographis paniculata", "multi-target anti-amyloid agents", "\u03b2-amyloid"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31319560", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "07", "Day": "17"}], "Language": ["eng"], "ELocationID": ["231", "10.3390/plants8070231"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "8", "Issue": "7", "PubDate": {"Year": "2019", "Month": "Jul", "Day": "17"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Multi-Target \u03b2-Protease Inhibitors from <i>Andrographis paniculata</i>: In Silico and In Vitro Studies.", "Abstract": {"AbstractText": ["Natural products derived from plants play a vital role in the discovery of new drug candidates, and these are used for novel therapeutic drug development. <i>Andrographis paniculata</i> and <i>Spilanthes paniculata</i> are used extensively as medicinal herbs for the treatment of various ailments, and are reported to have neuroprotective properties. \u03b2-amyloid is a microscopic brain protein whose significant aggregation is detected in mild cognitive impairment and Alzheimer's disease (AD) brains. The accumulation of \u03b2-amyloid disrupts cell communication and triggers inflammation by activating immune cells, leading to neuronal cell death and cognitive disabilities. The proteases acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta secretase-1 (BACE-1) have been reported to be correlated with the synthesis and growth of \u03b2-amyloid plaques in the brains of AD patients. In the present study, the phenolic compounds from <i>A. paniculata</i> and <i>S. paniculata</i> that have been reported in the literature were selected for the current investigation. Furthermore, we employed molecular docking and molecular dynamics studies of the phenolic compounds with the proteins AChE, BChE, and BACE-1 in order to evaluate the binding characteristics and identify potent anti-amyloid agents against the neurodegenerative diseases such as AD. In this investigation, we predicted three compounds from <i>A. paniculata</i> with maximum binding affinities with cholinesterases and BACE-1. The computational investigations predicted that these compounds follow the rule of five. We further evaluated these molecules for in vitro inhibition activity against all the enzymes. In the in vitro investigations, 3,4-di-<i>o</i>-caffeoylquinic acid (<b>5281780</b>), apigenin (<b>5280443</b>), and 7-<i>o</i>-methylwogonin (<b>188316</b>) were found to be strong inhibitors of AChE, BChE, and BACE-1. These findings suggest that these compounds can be potent multi-target inhibitors of the proteases that might cumulatively work and inhibit the initiation and formation of \u03b2-amyloid plaques, which is a prime cause of neurotoxicity and dementia. According to our knowledge, these findings are the first report on natural compounds isolated from <i>A. paniculata</i> as multi-target potent inhibitors and anti-amyloid agents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bio-Engineering, Birla Institute of Technology, Mesra, Ranchi 835215, India."}, {"Identifier": [], "Affiliation": "MGM's Institute of Biosciences & Technology, Mahatma Gandhi Mission, N-6, CIDCO, Aurangabad 431003, India."}], "LastName": "Panche", "ForeName": "Archana N", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bio-Engineering, Birla Institute of Technology, Mesra, Ranchi 835215, India. schandra@bitmesra.ac.in."}], "LastName": "Chandra", "ForeName": "Sheela", "Initials": "S"}, {"Identifier": ["0000-0002-9746-130X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MGM's Institute of Biosciences & Technology, Mahatma Gandhi Mission, N-6, CIDCO, Aurangabad 431003, India."}], "LastName": "Diwan", "ForeName": "A D", "Initials": "AD"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 1985;82:4245\u20134249. doi: 10.1073/pnas.82.12.4245.", "ArticleIdList": ["10.1073/pnas.82.12.4245", "PMC397973", "3159021"]}, {"Citation": "Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., M\u00fcller-Hill B. The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325:733\u2013736. doi: 10.1038/325733a0.", "ArticleIdList": ["10.1038/325733a0", "2881207"]}, {"Citation": "Zhang Y.W., Thompson R., Zhang H., Xu H. APP processing in Alzheimer\u2019s disease. Mol. Brain. 2011;4:3. doi: 10.1186/1756-6606-4-3.", "ArticleIdList": ["10.1186/1756-6606-4-3", "PMC3022812", "21214928"]}, {"Citation": "Cecilia R.A.S., Isabel C., Isabel G. Alzheimer\u2019s Disease Pathogenesis, Core Concepts, Shifting Paradigms and Therapeutic Targets. Intech Open; London, UK: 2011."}, {"Citation": "Selkoe D.J. Alzheimer\u2019s disease: Genes, proteins, and therapy. Physiol. Rev. 2001;81:741\u2013766. doi: 10.1152/physrev.2001.81.2.741.", "ArticleIdList": ["10.1152/physrev.2001.81.2.741", "11274343"]}, {"Citation": "Rochette M.J., Murphy M.P. Gamma secretase: Substrates and inhibitors. Mol. Neurobiol. 2002;26:81\u201395. doi: 10.1385/MN:26:1:081.", "ArticleIdList": ["10.1385/MN:26:1:081", "12392058"]}, {"Citation": "Tang J., Ghosh A. Treating transgenic Alzheimer mice with a \u03b2-secretase inhibitor, what have we learned? Aging. 2011;3:14\u201316. doi: 10.18632/aging.100267.", "ArticleIdList": ["10.18632/aging.100267", "PMC3047132", "21248377"]}, {"Citation": "Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 1999;14:419\u2013427. doi: 10.1006/mcne.1999.0811.", "ArticleIdList": ["10.1006/mcne.1999.0811", "10656250"]}, {"Citation": "Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H., Frigon N., Hong J., et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402:537\u2013540. doi: 10.1038/990114.", "ArticleIdList": ["10.1038/990114", "10591214"]}, {"Citation": "Vassar R., Bennet B., Babu-khan S., Kahn S., Mendiaz E., Denis P., Teplow D., Ross S., Amarante P., Loeloff R., et al. Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735\u2013741. doi: 10.1126/science.286.5440.735.", "ArticleIdList": ["10.1126/science.286.5440.735", "10531052"]}, {"Citation": "Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., et al. Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity. Nature. 1999;402:533\u2013537. doi: 10.1038/990107.", "ArticleIdList": ["10.1038/990107", "10591213"]}, {"Citation": "Kennedy M.E., Stamford A.W., Chen X., Cox K., Cumming J.N., Dockendorf M.F., Egan M., Ereshefsky L., Hodgson R.A., Hyde L.A., et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients. Sci. Transl. Med. 2016;8 doi: 10.1126/scitranslmed.aad9704.", "ArticleIdList": ["10.1126/scitranslmed.aad9704", "27807285"]}, {"Citation": "May P.C., Dean R.A., Lowe S.L., Martenyi F., Sheehan S.M., Boggs L.N., Monk S.A., Mathes B.M., Mergott D.J., Watson B.M., et al. Robust central reduction of amyloid-\u03b2 in humans with an orally available, non-peptidic \u03b2-secretase inhibitor. J. Neurosci. 2011;31:16507\u201316516. doi: 10.1523/JNEUROSCI.3647-11.2011.", "ArticleIdList": ["10.1523/JNEUROSCI.3647-11.2011", "PMC6633289", "22090477"]}, {"Citation": "May P.C., Willis B.A., Lowe S.L., Dean R.A., Monk S.A., Cocke P.J., Audia J.E., Boggs L.N., Borders A.R., Brier R.A., et al. Robust central reduction of amyloid-\u03b2 in humans with an orally available, non-peptidic beta-secretase inhibitor. J. Neurosci. Off. J. Soc. Neurosci. 2015;35:1199\u20131210. doi: 10.1523/JNEUROSCI.4129-14.2015.", "ArticleIdList": ["10.1523/JNEUROSCI.4129-14.2015", "PMC6605527", "25609634"]}, {"Citation": "Ishida T., Kato S. Theoretical Perspectives on the Reaction Mechanism of Serine Proteases:\u2009 The Reaction Free Energy Profiles of the Acylation Process. Process. J. Am. Chem. Soc. 2003;125:12035\u201312048. doi: 10.1021/ja021369m.", "ArticleIdList": ["10.1021/ja021369m", "14505425"]}, {"Citation": "Hedstrom L. Serine protease mechanism and specificity. Chem. Rev. 2002;102:4501\u20134523. doi: 10.1021/cr000033x.", "ArticleIdList": ["10.1021/cr000033x", "12475199"]}, {"Citation": "Topf M., Richards W.G. Theoretical studies on the deacylation step of serine protease catalysis in the gas phase, in solution, and in elastase. J. Am. Chem. Soc. 2004;126:14631\u201314641. doi: 10.1021/ja047010a.", "ArticleIdList": ["10.1021/ja047010a", "15521783"]}, {"Citation": "Quinn D.M. Acetylcholinesterase: Enzyme Structure, Reaction Dynamics, and Virtual Transition Stats. Chem. Rev. 1987;87:955\u2013979. doi: 10.1021/cr00081a005.", "ArticleIdList": ["10.1021/cr00081a005"]}, {"Citation": "Inestrosa N.C., Sagal J.P., Colombres M. Acetylcholinesterase interaction with Alzheimer amyloid beta. Subcell. Biochem. 2005;38:299\u2013317.", "ArticleIdList": ["15709485"]}, {"Citation": "Inestrosa N.C., Dinamarc M.C., Alvarez A. Amyloid-cholinesterase interactions. Implications for Alzheimer\u2019s disease. FEBS J. 2008;275:625\u2013632. doi: 10.1111/j.1742-4658.2007.06238.x.", "ArticleIdList": ["10.1111/j.1742-4658.2007.06238.x", "18205831"]}, {"Citation": "Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148:1204\u20131222. doi: 10.1016/j.cell.2012.02.040.", "ArticleIdList": ["10.1016/j.cell.2012.02.040", "PMC3319071", "22424230"]}, {"Citation": "Herrmann N., Chau S.A., Kircanski I., Lanctot K.L. Current and emerging drug treatment options for Alzheimer\u2019s disease: A systematic review. Drugs. 2011;71:2031\u20132065. doi: 10.2165/11595870-000000000-00000.", "ArticleIdList": ["10.2165/11595870-000000000-00000", "21985169"]}, {"Citation": "Danysz W., Parsons C. Alzheimer\u2019s disease beta-amyloid, glutamate, NMDA receptors and memantine-searching for the connections. Br. J. Pharmacol. 2012;16:324\u2013352. doi: 10.1111/j.1476-5381.2012.02057.x.", "ArticleIdList": ["10.1111/j.1476-5381.2012.02057.x", "PMC3481041", "22646481"]}, {"Citation": "Chen J., Xie J., Bao D., Liu S., Zhou Q. Total synthesis of (-)-galanthamine and (-)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive heck cyclization. Org. Lett. 2012;14:2714\u20132717. doi: 10.1021/ol300913g.", "ArticleIdList": ["10.1021/ol300913g", "22612349"]}, {"Citation": "Nikiforuk A., Potasiewicz A., Kos T., Popik P. The combination of memantine and galantamine improves cognition in rats: The synergistic role of the \u03b17 nicotinic acetylcholine and NMDA receptors. Behav. Brain Res. 2016;313:214\u2013218. doi: 10.1016/j.bbr.2016.07.023.", "ArticleIdList": ["10.1016/j.bbr.2016.07.023", "27435422"]}, {"Citation": "Peters O., Fuentes M., Joachim L.K., Jessen F., Luckhaus C., Kornhuber J., Pantel J., H\u00fcll M., Schmidtke K., R\u00fcther E., et al. Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug na\u00efve patients with mild-to-moderate Alzheimer\u2019s disease. Transl. Res. Clin. Interv. 2015;1:198\u2013204. doi: 10.1016/j.trci.2015.10.001.", "ArticleIdList": ["10.1016/j.trci.2015.10.001", "PMC5975055", "29854939"]}, {"Citation": "Kaye A.D., Liu H., Fox C., Baluch A., Sutker P.B. Psychiatric and behavioral disorders A2. In: Fleisher L.A., editor. Anesthesia and Uncommon Diseases. 6th ed. Elsevier; Philadelphia, PA, USA: 2012. pp. 444\u2013469."}, {"Citation": "Darvesh S., Hopkins D., Geula C. Neurobiology of Butyrylcholinesterase. Nat. Rev. Neurosci. 2003;4:131\u2013138. doi: 10.1038/nrn1035.", "ArticleIdList": ["10.1038/nrn1035", "12563284"]}, {"Citation": "Turner A., Hartman L., Nakayama K., Acey R. The Role of Butyrylcholinesterase in Beta-Amyloid Formation in Neuroblastoma Cells. FASEB J. 2015;29:1.", "ArticleIdList": ["0"]}, {"Citation": "Matsuoka S., Inoue M. Application of REDOR NMR in natural product chemistry. Chem. Commun. 2009:5664\u20135675. doi: 10.1039/b910230b.", "ArticleIdList": ["10.1039/b910230b", "19774235"]}, {"Citation": "Kingston D.G.I. Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation. J. Nat. Prod. 2011;74:496\u2013511. doi: 10.1021/np100550t.", "ArticleIdList": ["10.1021/np100550t", "PMC3061248", "21138324"]}, {"Citation": "Maione F., Russo R., Khan H., Mascolo N. Medicinal plants with anti-inflammatory activities. Nat. Prod. Res. 2016;30:1343\u20131352. doi: 10.1080/14786419.2015.1062761.", "ArticleIdList": ["10.1080/14786419.2015.1062761", "26221780"]}, {"Citation": "Mishra B.B., Tiwari V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem. 2011;46:4769\u20134807. doi: 10.1016/j.ejmech.2011.07.057.", "ArticleIdList": ["10.1016/j.ejmech.2011.07.057", "21889825"]}, {"Citation": "Khan H., Amin S. ACE Inhibition of Plant Alkaloids Targeted Approach for Selective Inhibition. Mini Rev. Org. Chem. 2017;14:85\u201389. doi: 10.2174/1570193X14666161201124705.", "ArticleIdList": ["10.2174/1570193X14666161201124705"]}, {"Citation": "Khan H. Brilliant future of phytomedicines in the light of latest technological developments. J. Phytopharmacol. 2015;4:58\u201360."}, {"Citation": "Feng Y., Wang X. Antioxidant Therapies for Alzheimer\u2019s Disease. Oxid. Med. Cell. Longev. 2012;2012:472\u2013932. doi: 10.1155/2012/472932.", "ArticleIdList": ["10.1155/2012/472932", "PMC3410354", "22888398"]}, {"Citation": "Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197\u20132204. doi: 10.1212/01.wnl.0000271090.28148.24.", "ArticleIdList": ["10.1212/01.wnl.0000271090.28148.24", "17568013"]}, {"Citation": "Dolan H., Troncoso J., Crain B., Resnick S., Zonderman A., O\u2019Brien R. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of aging cohort. Ann. Neurol. 2010;68:231\u2013240.", "ArticleIdList": ["PMC3030772", "20695015"]}, {"Citation": "Tang W., Eisenbrand G. Chinese Drugs of Plant Origin, Chemistry, Pharmacology and Use in Traditional and Modern Medicine. Springer; Heidelberg/Berlin, Germany: 1992."}, {"Citation": "Gamble J.S. Flora of the Presidency of Madras. Botanical Survey of India; Calcutta, India: 1956."}, {"Citation": "Lim J.C.W., Chan T.K., Ng D.S.W., Sagineedu S.R., Stanslas J., Wong W.S.F. Andrographolide and its analogues: Verstaile bioactive molecules for combating inflammation and cancer. Clin. Exp. Pharmacol. Physiol. 2012;39:300\u2013310. doi: 10.1111/j.1440-1681.2011.05633.x.", "ArticleIdList": ["10.1111/j.1440-1681.2011.05633.x", "22017767"]}, {"Citation": "Prachayasittukul S., Suphapong S., Worachartcheewan A., Lawung R., Ruchirawat S., Prachayasittukul V. Bioactive metabolites from Spilanthes acmella Murr. Molecules. 2009;14:850\u2013867. doi: 10.3390/molecules14020850.", "ArticleIdList": ["10.3390/molecules14020850", "PMC6253828", "19255544"]}, {"Citation": "Thakur H.R., Bhamare M.R. Phytochemical and Antimicrobial activity of Spilanthes acmella. Adv. Pharmacol. Sci. 2015;4:723\u2013733."}, {"Citation": "Sana H., Rani A.S., Sulakshana G. Determination of Antioxidant Potential in Spilanthes acmella using DPPH assay. Int. J. Curr. Microbiol. Appl. Sci. 2014;3:219\u2013223."}, {"Citation": "Urankar M., Desai A., Bhat R. Review on medicinal herb genus Spilanthes and Applications in oral hygiene. Univ. J. Pharm. 2013;2:25\u201333."}, {"Citation": "Suwanjang W., Khongniam B., Srisung S., Prachayasittikul S., Prachayasittikul S. Neuroprotective effect of Spilanthes acmella Murr on pesticide-induced neuronal cells death. Asian Pacific J. Trop. Med. 2016;5:1\u20137. doi: 10.1016/j.apjtm.2016.11.012.", "ArticleIdList": ["10.1016/j.apjtm.2016.11.012", "28107862"]}, {"Citation": "Rao Y.K., Vimalamma G., Rao C.V., Tzeng Y. Flavonoids and andrographolides from Andrographis paniculata. Phytochemistry. 2004;65:2317\u20132321. doi: 10.1002/chin.200510225.", "ArticleIdList": ["10.1002/chin.200510225", "15381002"]}, {"Citation": "Gulam N.N., Wani T.A., Shrivastava M., Wani A., Shah S.N. Spilanthes acmella an endangered medicinal plant\u2014Its Traditional, Phytochemical and Therapeutic properties\u2014An overview. Int. J. Adv. Res. 2016;4:627\u2013639."}, {"Citation": "Ncube B., Nair J.J., R\u00e1rov\u00e1 L., Strnad M., Finnie J.F., Van Staden J. Seasonal pharmacological properties and alkaloid content in Cyrtanthus contractus N.E. Br. S. Afr. J. Bot. 2015;97:69\u201376. doi: 10.1016/j.sajb.2014.12.005.", "ArticleIdList": ["10.1016/j.sajb.2014.12.005"]}, {"Citation": "Stafford G.I., Pedersen M.E., Van Staden J., J\u00e4ger A.K. Review on plants with CNS effects used in traditional South African medicine against mental diseases. J. Ethnopharmacol. 2008;119:513\u2013537. doi: 10.1016/j.jep.2008.08.010.", "ArticleIdList": ["10.1016/j.jep.2008.08.010", "18775771"]}, {"Citation": "Uysal S., Zengina G., Mahomoodally M.F., Yilmaz M.A., Aktumsek A. Chemical profile, antioxidant properties and enzyme inhibitory effects of the root extracts of selected Potentilla species. S. Afr. J. Bot. 2019;120:124\u2013128. doi: 10.1016/j.sajb.2018.01.014.", "ArticleIdList": ["10.1016/j.sajb.2018.01.014"]}, {"Citation": "Sinha S., Kumar B., Luqman S., Singh D.K. Neuroprotective potential of Cucurbita maxima Duchesne ex Poir, Caeselpenia bunduc (L.) Roxb and Bombax ceiba Linn extracts. S. Afr. J. Bot. 2019;120:319\u2013325. doi: 10.1016/j.sajb.2018.09.027.", "ArticleIdList": ["10.1016/j.sajb.2018.09.027"]}, {"Citation": "Akata G., Zenginb C.M.N., Picot M.F. Enzyme inhibitory and antioxidant properties of six mushroom species from the Agaricaceae family. S. Afr. J. Bot. 2019;120:95\u201399. doi: 10.1016/j.sajb.2018.01.008.", "ArticleIdList": ["10.1016/j.sajb.2018.01.008"]}, {"Citation": "Ozarowski M., Mikolajczak P.L., Piasecka A., Kujawski R., Bartkowiak-Wieczorek J., Bogacz A., Szulc M., Kaminska E., Kujawska M., Gryszczynska A., et al. Effect of Salvia miltiorrhiza root extract on brain acetylcholinesterase and butyrylcholinesterase activities, their mRNA levels and memory evaluation in rats. Physiol. Behav. 2017;173:223\u2013230. doi: 10.1016/j.physbeh.2017.02.019.", "ArticleIdList": ["10.1016/j.physbeh.2017.02.019", "28219697"]}, {"Citation": "Ahmad A., Ramasamy K., Majeed A.B.A., Mani V. Enhancement of \u03b2-secretase inhibition and antioxidant activities of tempeh, a fermented soybean cake through enrichment of bioactive aglycones. Pharm. Biol. 2015;53:758\u2013766. doi: 10.3109/13880209.2014.942791.", "ArticleIdList": ["10.3109/13880209.2014.942791", "25756802"]}, {"Citation": "Aliaga K.J., Besc\u00f3s P.B., Benedi J., Arag\u00f3n S.M. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci. 2011;89:939\u2013945. doi: 10.1016/j.lfs.2011.09.023.", "ArticleIdList": ["10.1016/j.lfs.2011.09.023", "22008478"]}, {"Citation": "Wang S., Wang Y., Su Y., Zhou W., Yang S., Zhang R., Zhao M., Li Y., Zhang Z., Zhan D., et al. Rutin inhibits \u03b2-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology. 2012;33:482\u2013490. doi: 10.1016/j.neuro.2012.03.003.", "ArticleIdList": ["10.1016/j.neuro.2012.03.003", "22445961"]}, {"Citation": "Fiorentino A., D\u2019Abrosca B., Pacifico S., Mastellone C., Piccolella S., Monaco P. Isolation and Structure Elucidation of Antioxidant Polyphenols from Quince (Cydonia vulgaris) Peels. J. Agric. Food Chem. 2008;56:2660\u20132667. doi: 10.1021/jf800059r.", "ArticleIdList": ["10.1021/jf800059r", "18348529"]}, {"Citation": "Hoper L., Cassidy A. A review of the health care potential of bioactive compounds. J. Sci. Food Agric. 2006;86:1805\u20131813. doi: 10.1002/jsfa.2599.", "ArticleIdList": ["10.1002/jsfa.2599"]}, {"Citation": "Pu F., Ren X.L., Zhang X.P. Phenolic compounds and antioxidant activity in fruits of six Diospyros kaki genotypes. Eur. Food. Res. Technol. 2013;237:923\u2013932. doi: 10.1007/s00217-013-2065-z.", "ArticleIdList": ["10.1007/s00217-013-2065-z"]}, {"Citation": "Bolognesi M.L. Polypharmacology in a single drug: Multitarget drugs. Curr. Med. Chem. 2013;20:1639\u20131645. doi: 10.2174/0929867311320130004.", "ArticleIdList": ["10.2174/0929867311320130004", "23410164"]}, {"Citation": "Bolognesi M.L., Cavalli A. Multitarget drug discovery and polypharmacology. Chem. Med. Chem. 2016;11:1190\u20131192. doi: 10.1002/cmdc.201600161.", "ArticleIdList": ["10.1002/cmdc.201600161", "27061625"]}, {"Citation": "Morphy R., Kay C., Rankovic Z. From magic bullets to designed multiple ligands. Drug Discov. Today. 2004;9:641\u2013651. doi: 10.1016/S1359-6446(04)03163-0.", "ArticleIdList": ["10.1016/S1359-6446(04)03163-0", "15279847"]}, {"Citation": "Youdim M.B.H., Buccafusco J.J. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol. Sci. 2005;26:27\u201335. doi: 10.1016/j.tips.2004.11.007.", "ArticleIdList": ["10.1016/j.tips.2004.11.007", "15629202"]}, {"Citation": "Roth B.L., Sheffler D.J., Kroeze W.K. Magic shotguns versus magic bullets: Selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov. 2004;3:353\u2013359. doi: 10.1038/nrd1346.", "ArticleIdList": ["10.1038/nrd1346", "15060530"]}, {"Citation": "Ramsay R.R., Popovic-Nikolic M.R., Nokolic K., Uliassi E., Bolognesi M.L. A perspective on multi-target drug discovery and design for complex diseases. Clin. Trans. Med. 2018;7:3. doi: 10.1186/s40169-017-0181-2.", "ArticleIdList": ["10.1186/s40169-017-0181-2", "PMC5770353", "29340951"]}, {"Citation": "Wu T.S., Chen H.J., Damu A.G., Kuo P.C., Su C.R., Lee E.J., Teng C.M. Flavonoids and ent-labdane diterpenoids from Andrographis paniculata and their antiplatelet aggregatory and vasorelaxing effects. J. Asian Nat. Prod. Res. 2008;10:17\u201324. doi: 10.1080/10286020701273627.", "ArticleIdList": ["10.1080/10286020701273627", "18058376"]}, {"Citation": "Radic Z., Pickering N.A., Vellom D.C., Camp S., Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry. 1993;32:12074\u201312084. doi: 10.1021/bi00096a018.", "ArticleIdList": ["10.1021/bi00096a018", "8218285"]}, {"Citation": "Radic Z., Quinn D.M., Vellom D.C., Camp S., Taylor P. Allosteric control of acetylcholinesterase catalysis by fasciculin. J. Biol. Chem. 1995;270:20391\u201320399. doi: 10.1074/jbc.270.35.20391.", "ArticleIdList": ["10.1074/jbc.270.35.20391", "7657613"]}, {"Citation": "Vellom D.C., Radic Z., Li Y., Pickering N.A., Camp S., Taylor P. Amino acid residues controlling acetylcholinesterase and butyryl- cholinesterase specificity. Biochemistry. 1993;32:12\u201317. doi: 10.1021/bi00052a003.", "ArticleIdList": ["10.1021/bi00052a003", "8418833"]}, {"Citation": "Kryger G., Silman I., Sussman J.L. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo califor-nica. J. Physiol. Paris. 1998;92:191\u2013194. doi: 10.1016/S0928-4257(98)80008-9.", "ArticleIdList": ["10.1016/S0928-4257(98)80008-9", "9789806"]}, {"Citation": "Felder C.E., Harel M., Silman I., Sussman J.L. Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase. Acta Crystallogr. D Biol. Crystallogr. 2002;58:1765\u20131771. doi: 10.1107/S0907444902011642.", "ArticleIdList": ["10.1107/S0907444902011642", "12351819"]}, {"Citation": "Ashani Y., Peggins J.O., Doctor B.P. Mechanism of inhibition of cho-linesterases by Huperzine A. Biochem. Biophys. Res. Commun. 1992;184:719\u2013726. doi: 10.1016/0006-291X(92)90649-6.", "ArticleIdList": ["10.1016/0006-291X(92)90649-6", "1575745"]}, {"Citation": "Davis A., Teague S. Hydrogen bonding, hydrophobic interactions and failure of the rigid receptor hypothesis. Angew. Chem. Int. Ed. 1999;38:736\u2013749. doi: 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R.", "ArticleIdList": ["10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R", "29711793"]}, {"Citation": "Varma A., Patil R., Das S., Stanley A., Yadav L., Akulapalli S. Optimized hydrophobic interactions and hydrogen bonding at the target ligand interface leads pathway of Drug designing. PLoS ONE. 2010;5:e12029.", "ArticleIdList": ["PMC2922327", "20808434"]}, {"Citation": "Liu S., Fu R., Cheng X., Chen S., Zhou L. Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis(COMBINE) BMC Struct. Biol. 2012;12:21. doi: 10.1186/1472-6807-12-21.", "ArticleIdList": ["10.1186/1472-6807-12-21", "PMC3533579", "22925713"]}, {"Citation": "Bourne Y., Kolb H.C., Radic Z., Sharpless K.B., Taylor P., Marchot P. Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. Proc. Natl. Acad. Sci. USA. 2004;101:1449\u20131454. doi: 10.1073/pnas.0308206100.", "ArticleIdList": ["10.1073/pnas.0308206100", "PMC341740", "14757816"]}, {"Citation": "Darvesh S., Macdonald I.R., Martin E., Rosenberry T.L. Probing the Peripheral Site of Human Butyrylcholinesterase. Biochemistry. 2012;51:7046\u20137053.", "ArticleIdList": ["PMC3438789", "22901043"]}, {"Citation": "Mallender W.D., Szegletes T., Rosenberry T.L. Acetylthiocholine binds to Asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway. Biochemistry. 2000;39:7753\u20137763. doi: 10.1021/bi000210o.", "ArticleIdList": ["10.1021/bi000210o", "10869180"]}, {"Citation": "Nachmansohn D., Wilson I.B. The enzymic hydrolysis and synthesis of acetylcholine. Adv. Enzymol. Relat. Subj. Biochem. 1951;12:259\u2013339.", "ArticleIdList": ["14885021"]}, {"Citation": "Masson P., Froment M.T., Bartels C.F., Lockridge O. Asp70 in the peripheral anionic site of human butyrylcholines-terase. Eur. J. Biochem. 1996;235:36\u201348. doi: 10.1111/j.1432-1033.1996.00036.x.", "ArticleIdList": ["10.1111/j.1432-1033.1996.00036.x", "8631355"]}, {"Citation": "Johnson G., Moore S.W. The Peripheral Anionic Site of Acetylcholinesterase: Structure, Functions and Potential Role in Rational Drug Design. Curr. Pharm. Des. 2006;12:217\u2013225. doi: 10.2174/138161206775193127.", "ArticleIdList": ["10.2174/138161206775193127", "16454738"]}, {"Citation": "Radic Z., Duran R., Vellom D.C., Li Y., Cervenansky C., Taylor P. Site of fasciculin interaction with acetylcholinesterase. J. Biol. Chem. 1994;269:11233\u201311239.", "ArticleIdList": ["8157652"]}, {"Citation": "Jung H.A., Shrestha S., Seong S.H., Paudel P., Choi J.S. Structure Related Inhibition of Enzyme Systems in Cholinesterases and BACE1 In vitro by Naturally occurring Naphthopyrone and Its Glycosides Isolated from Cassia obtusifolia. Molecules. 2018;23:69. doi: 10.3390/molecules23010069.", "ArticleIdList": ["10.3390/molecules23010069", "PMC6017707", "29283428"]}, {"Citation": "Matheus F., Vargas J.A.R., Lopez A.G., Pi\u00f1ol M.C. Molecular docking study on the interaction between 2-substituted-4,5-difuryl Imidazoles with different Protein Target for antileishmanial activity. J. Appl. Pharm. Sci. 2018;8:14\u201322. doi: 10.7324/JAPS.2018.8303.", "ArticleIdList": ["10.7324/JAPS.2018.8303"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001;46:3\u201326. doi: 10.1016/S0169-409X(00)00129-0.", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}, {"Citation": "QikProp. Schrodinger, LLC; New York, NY, USA: 2015. Version 3.5."}, {"Citation": "Ghose A.K., Herbertz T., Hudkins R.L., Dorsey B.D., Mallamo J.P. Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chem. Neurosci. 2012;3:50\u201368. doi: 10.1021/cn200100h.", "ArticleIdList": ["10.1021/cn200100h", "PMC3260741", "22267984"]}, {"Citation": "Gerald M., Petita J., Meuricea N., Kaisera C. Softening the Rule of Five\u2014where to draw the line? Bioorg. Med. Chem. 2012;20:5343\u20135351.", "ArticleIdList": ["PMC4209914", "22222160"]}, {"Citation": " [(accessed on 6 April 2019)]; Available online:  http://www.bccancer.bc.ca/health-professionals/clinical-resources/cancer-drug-manual."}, {"Citation": "Ahmed M., Hafsa A. Designing second generation anti-alzheimer compounds as inhibitors of human acetylcholinesterase: Computational screening of synthetic molecules and dietary phytochemicals. PLoS ONE. 2015;10:e0136509. doi: 10.1371/journal.pone.0136509.", "ArticleIdList": ["10.1371/journal.pone.0136509", "PMC4556483", "26325402"]}, {"Citation": "Adcock S.A., McCammon J.A. Molecular dynamics: Survey of methods for simulating the activity of protein. Chem. Rev. 2006;106:1589\u20131615. doi: 10.1021/cr040426m.", "ArticleIdList": ["10.1021/cr040426m", "PMC2547409", "16683746"]}, {"Citation": "Cardone A., Hassan S.A., Albers R.W., Sriram R.D., Pant H.C. Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP. J. Mole. Biol. 2010;401:478\u2013492. doi: 10.1016/j.jmb.2010.06.040.", "ArticleIdList": ["10.1016/j.jmb.2010.06.040", "PMC2919306", "20599546"]}, {"Citation": "Humphrey W., Dalke A., Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. Model. 1996;14:33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Mart\u00ednez L. Automatic Identification of Mobile and Rigid Substructures in Molecular Dynamics Simulations and Fractional Structural Fluctuation Analysis. PLoS ONE. 2015;10:e0119264. doi: 10.1371/journal.pone.0119264.", "ArticleIdList": ["10.1371/journal.pone.0119264", "PMC4376797", "25816325"]}, {"Citation": "Cui C.B., Jeong S.K., Lee Y.S., Lee S.O., Kang I.J., Lim S.S. Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princes on rat lens aldose reductase and on the formation of advanced glycation end product. J. Korean Soc. Appl. Biol. Chem. 2009;52:655\u2013662. doi: 10.3839/jksabc.2009.109.", "ArticleIdList": ["10.3839/jksabc.2009.109"]}, {"Citation": "Shimozono H., Kobori M., Shinmoto H., Tsushida T. Suppression of the Melanogenesis of Mouse Melanoma B 16 Cells by Sweet Potato Extract. Nippon Shokuhin Kagaku Kaishi. 1996;43:313\u2013317. doi: 10.3136/nskkk.43.313.", "ArticleIdList": ["10.3136/nskkk.43.313"]}, {"Citation": "Yagasaki K., Miura Y., Okauchi R., Furuse T. Inhibitory effects of chlorogenic acid and its related compounds on the invasion of hepatoma cells in culture. Cytochemistry. 2000;33:229\u2013235.", "ArticleIdList": ["PMC3466720", "19002830"]}, {"Citation": "Liu H., Zhang X., Wu C., Wu H., Guo P., Xu X. Anti-hyperlipidemic caffeoylquinic acids from the fruits of Pandanus tectorius Soland. J. Appl. Pharm. Sci. 2013;3:016\u2013019."}, {"Citation": "Kim K.H., Kim Y.H., Lee K.R. Isolation of quinic acid derivatives and flavonoids from the aerial parts of Lactuca indica L. and their hepatoprotective activity in vitro. Bioorg. Med. Chem. Lett. 2007;17:6739\u20136743. doi: 10.1016/j.bmcl.2007.10.046.", "ArticleIdList": ["10.1016/j.bmcl.2007.10.046", "18029179"]}, {"Citation": "Hyun Y.J., Piaoa M.J., Kanga K.A., Ryua Y.S., Zhena A.O., Choa S.J., Kanga H.K., Koha Y.S., Ahn M.J., Kim T.H., et al. 3,4-Dicaffeoylquinic acid protects human keratinocytes against environmental oxidative damage. J. Funct. Foods. 2019;52:430\u2013441. doi: 10.1016/j.jff.2018.11.026.", "ArticleIdList": ["10.1016/j.jff.2018.11.026"]}, {"Citation": "Hadi A.H.A., Fadaeinasab M., Kia Y., Basiri A., Murugaiyah V. Cholinesterase enzymes inhibitors from the leaves of Rauvolfia Reflexa and their Molecular Docking Study. Molecules. 2013;18:3779\u20133788.", "ArticleIdList": ["PMC6270359", "23529036"]}, {"Citation": "Wei H., Tye L., Bresnick E., Birt D.F. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res. 1990;50:499\u2013502.", "ArticleIdList": ["2105157"]}, {"Citation": "Verbeek R., Plomp A.C., Van tol E.A.F., Van Noort J.M. The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem. Pharmacol. 2004;68:621\u2013629. doi: 10.1016/j.bcp.2004.05.012.", "ArticleIdList": ["10.1016/j.bcp.2004.05.012", "15276069"]}, {"Citation": "Johnson J.L., Rupasinghe S.G., Stefani F., Schuler M.A., De Mejia E.G. Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3\u03b2 enzymatic activity by lowering the interaction energy within the binding cavity. J. Med. Food. 2011;14:325\u2013333. doi: 10.1089/jmf.2010.0310.", "ArticleIdList": ["10.1089/jmf.2010.0310", "PMC3123937", "21443429"]}, {"Citation": "Shoubaky G.A.E., Abdel-Daim M.M., Mansour M.H., Salem E.A. Isolation and Identification of a Flavone Apigenin from Marine Red Alga Acanthophora spicifera with Antinociceptive and Anti-Inflammatory Activities. J. Exp. Neurosci. 2016;10:21\u201329. doi: 10.4137/JEN.S25096.", "ArticleIdList": ["10.4137/JEN.S25096", "PMC4760667", "26917974"]}, {"Citation": "Yan X., Qi M., Li P., Zhan Y., Shao H. Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci. 2017;7:50. doi: 10.1186/s13578-017-0179-x.", "ArticleIdList": ["10.1186/s13578-017-0179-x", "PMC5629766", "29034071"]}, {"Citation": "Muhammad A., Tel-Cayan G., \u00d6zt\u00fcrk M., Nadeem S., Duru M.E., Anis I., Ng S.W., Shah M.R. Biologically active flavonoids from Dodonaea viscosa and their structure\u2013activity relationships. Ind. Crops Prod. 2015;78:66\u201372. doi: 10.1016/j.indcrop.2015.10.011.", "ArticleIdList": ["10.1016/j.indcrop.2015.10.011"]}, {"Citation": "Chandrasekaran C.V., Thiyagarajan P., Deepak H.B., Agarwal A. In vitro modulation of LPS/calcimycin induced inflammatory and allergic mediators by pure compounds of Andrographis paniculata (King of bitters) extract. Int. Immunopharmacol. 2011;11:79\u201384. doi: 10.1016/j.intimp.2010.10.009.", "ArticleIdList": ["10.1016/j.intimp.2010.10.009", "21034865"]}, {"Citation": "Larik F.A., Shah M.S., Saeed A., Shah H.S., Channar P.A., Bolte M., Iqbal J. New cholinesterase inhibitors for Alzheimer\u2019s disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives. Int. J. Biol. Macromol. 2018;116:144\u2013150. doi: 10.1016/j.ijbiomac.2018.05.001.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.05.001", "29729344"]}, {"Citation": "Kostelnik A., Pohanka M. Inhibition of Acetylcholinesterase and Butyrylcholinesterase by a Plant Secondary Metabolite Boldine. Bio. Med. Res. Int. 2018;2018:9634349. doi: 10.1155/2018/9634349.", "ArticleIdList": ["10.1155/2018/9634349", "PMC5907398", "29850593"]}, {"Citation": "Dajas F. Life or death: Neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 2012;143:383\u2013396. doi: 10.1016/j.jep.2012.07.005.", "ArticleIdList": ["10.1016/j.jep.2012.07.005", "22820241"]}, {"Citation": "Bahar E., Kim J.Y., Yoon H. Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS/NF-\u03baB and HO-1/Nrf2 pathways. Int. J. Mol. Sci. 2017;18:1989. doi: 10.3390/ijms18091989.", "ArticleIdList": ["10.3390/ijms18091989", "PMC5618638", "28914791"]}, {"Citation": "Mukherjee P.K., Kumar V., Houghton P.J. Acetylcholinesterase inhibitors from plants. Phytother. Res. 2007;21:1142\u20131145. doi: 10.1002/ptr.2224.", "ArticleIdList": ["10.1002/ptr.2224", "17639556"]}, {"Citation": "Greig N.H., Utsuki T., Ingram D.K., Wang Y., Pepeu G., Scali C., Yu Q.S., Mamczarz J., Holloway H.W., Giordano T., et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent. Proc. Natl. Acad. Sci. USA. 2005;102:17213\u201317218. doi: 10.1073/pnas.0508575102.", "ArticleIdList": ["10.1073/pnas.0508575102", "PMC1288010", "16275899"]}, {"Citation": "Furukawa-Hibi Y., Alkam T., Nitta A., Matsuyama A., Mizoguchi H., Suzuki K., Moussaoui S., Yu Q.S., Greig N.H., Nagai T., et al. Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-\u03b2 peptide in mice. Behav. Brain Res. 2011;225:222\u2013229. doi: 10.1016/j.bbr.2011.07.035.", "ArticleIdList": ["10.1016/j.bbr.2011.07.035", "PMC4979006", "21820013"]}, {"Citation": "Peters F., Salihoglu H., Rodrigues E., Herzog E., Blume T., Filser S., Dorostkar M., Shimshek D.R., Brose N., Neumann U., et al. BACE1 inhibition more effectively suppresses initiation than progression of \u03b2-amyloid pathology. Acta Neuropathol. 2018;135:695\u2013710. doi: 10.1007/s00401-017-1804-9.", "ArticleIdList": ["10.1007/s00401-017-1804-9", "PMC5904228", "29327084"]}, {"Citation": "Kim M.K., Choi S.M., Kim B.C., Cho Y.H., Choi K.H., Chang J., Park M.S., Cho K.H., Kim J.K. Effects of Flavonoid Compounds on \u03b2-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons. Chonnam. Med. J. 2014;50:45\u201351.", "ArticleIdList": ["PMC4161760", "25229015"]}, {"Citation": "Butler M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004;67:2141\u20132153. doi: 10.1021/np040106y.", "ArticleIdList": ["10.1021/np040106y", "15620274"]}, {"Citation": "Wang C.N., Chi C.W., Lin Y.L., Chen C.F., Shiao Y.J. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 2001;276:5287\u20135295. doi: 10.1074/jbc.M006406200.", "ArticleIdList": ["10.1074/jbc.M006406200", "11083861"]}, {"Citation": "Dajas F., Rivera F., Blasina F., Arredondo F., Echeverry C., Lafon L., Morquio A., Heizen H. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox. Res. 2003;5:425\u2013432. doi: 10.1007/BF03033172.", "ArticleIdList": ["10.1007/BF03033172", "14715446"]}, {"Citation": "Mandel S., Youdim M.B. Catechin polyphenols: Neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic. Biol. Med. 2004;37:304\u2013317. doi: 10.1016/j.freeradbiomed.2004.04.012.", "ArticleIdList": ["10.1016/j.freeradbiomed.2004.04.012", "15223064"]}, {"Citation": "Simonyi A., Wang Q., Miller R.L., Yusof M., Shelat P.B., Sun A.Y., Sun G.Y. Polyphenols in cerebral ischemia. Mol. Neurobiol. 2005;31:135\u2013147. doi: 10.1385/MN:31:1-3:135.", "ArticleIdList": ["10.1385/MN:31:1-3:135", "15953817"]}, {"Citation": "Borowiec K., Szwajgier D., Pustelniak K. The Neuroprotective Effects of Phenolic Acids: Molecular Mechanism of Action. Nutrients. 2017;9:477.", "ArticleIdList": ["PMC5452207", "28489058"]}, {"Citation": "Wang Y., Xiao J., Suzek T., Zhang J., Wang J., Bryant S. PubChem: A public information system for analysing bioactivities of small molecules. Nucleic Acids Res. 2009;2009:1\u201311. doi: 10.1093/nar/gkp456.", "ArticleIdList": ["10.1093/nar/gkp456", "PMC2703903", "19498078"]}, {"Citation": "Degtyarenko K., Matos P., Ennis M., Hasting J., Zbinden M., McNaught A., Alcantara R., Darsow M., Guedj M., Ashburner M. CHEBI: A database and ontology for chemical entities of biological interest. Nucleic Acids. Res. 2008;36:D344\u2013D350. doi: 10.1093/nar/gkm791.", "ArticleIdList": ["10.1093/nar/gkm791", "PMC2238832", "17932057"]}, {"Citation": "Protein Preparation Wizard 2015-1. Schr\u00f6dinger, LLC; New York, NY, USA: 2015. Epik Version 2.4; Impact Version 5.9; Prime Version 3.2."}, {"Citation": "Sastry G.M., Adzhigirey M., Day T., Annabhimoju R., Sherman W.J. Comput. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Aided Mol. Des. 2013;27:221\u2013234. doi: 10.1007/s10822-013-9644-8.", "ArticleIdList": ["10.1007/s10822-013-9644-8", "23579614"]}, {"Citation": "Kaminski G., Friesner R., Tirado-Rives J., Jorgensen W. Evaluation and reparametrization of the OPLS-aA forcefield for proteins via comparison with accurate quantum chemical calculations on peptides. J. Phys. Chem. 2001;105:6474\u20136487. doi: 10.1021/jp003919d.", "ArticleIdList": ["10.1021/jp003919d"]}, {"Citation": "LigPrep. Schrodinger, LLC; New York, NY, USA: 2015. Version 3.3."}, {"Citation": "Glide. Schrodinger, LLC; New York, NY, USA: 2015. Version 6.6."}, {"Citation": "Bekker H., Berendsen H.J.C., Dijkstra E.J., Achterop S., Vondrumen R., Van Der Spoel D., Sijbers A., Keegstra H., Renardus M.K.R. In: Physics Computing 92. DeGroot R.A., Nadrchal J., editors. World Scientific Publishing; Singapore: 1993. pp. 252\u2013256."}, {"Citation": "Van der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J.C. GROMACS: Fast, flexible, and free. J. Comp. Chem. 2005;26:1701\u20131718. doi: 10.1002/jcc.20291.", "ArticleIdList": ["10.1002/jcc.20291", "16211538"]}, {"Citation": "Abraham M.J., Murtola T., Schulz R., Pall S., Smith J.C., Hess B., Lindah E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Schuttelkopf W., Van Aalten D.M.F. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. 2004;60:1355\u20131363. doi: 10.1107/S0907444904011679.", "ArticleIdList": ["10.1107/S0907444904011679", "15272157"]}, {"Citation": "Citron M. Beta-secretase as a target for the treatment of Alzheimer\u2019s disease. J. Neurosci. Res. 2002;70:373\u2013379. doi: 10.1002/jnr.10393.", "ArticleIdList": ["10.1002/jnr.10393", "12391600"]}, {"Citation": "Hong L., Turner R.T., Koelsch G., Ghosh A.K., Tang J. Memapsin 2 (beta-secretase) as a therapeutic target. Biochem. Soc. Trans. 2002;30:530\u2013534. doi: 10.1042/bst0300530.", "ArticleIdList": ["10.1042/bst0300530", "12196130"]}, {"Citation": "Roberds S.L., Anderson J., Basi G., Bienkowski M.J., Branstetter D.G., Chen K.S., Freedman S.B., Frigon N.L., Games D., Hu K., et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: Implications for Alzheimer\u2019s disease therapeutics. Hum. Mol. Genet. 2001;10:1317\u20131324. doi: 10.1093/hmg/10.12.1317.", "ArticleIdList": ["10.1093/hmg/10.12.1317", "11406613"]}, {"Citation": "Jung H.A., Min B.S., Yokozawa T., Lee J.H., Kim Y.S., Choi J.S. Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol. Pharm. Bull. 2009;32:1433\u20131438. doi: 10.1248/bpb.32.1433.", "ArticleIdList": ["10.1248/bpb.32.1433", "19652386"]}, {"Citation": "Ellman G.L., Courtney K.D., Andres V.J., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}]}], "History": [{"Year": "2019", "Month": "5", "Day": "1"}, {"Year": "2019", "Month": "6", "Day": "15"}, {"Year": "2019", "Month": "6", "Day": "20"}, {"Year": "2019", "Month": "7", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "7", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["31319560", "PMC6681301", "10.3390/plants8070231", "plants8070231"]}}]}